You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 25, 2024

List of Excipients in API patisiran

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing patisiran

Subscribe to access the full database, or Subscribe
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Alnylam Pharmaceuticals Inc	ONPATTRO	patisiran	71336-1000	1,2-DIMYRISTOYL-SN-GLYCERO-3-CARBOXAMINOPROPYLPOLYETHYLENE GLYCOL 2000 METHYL ETHER	2030-11-10
Alnylam Pharmaceuticals Inc	ONPATTRO	patisiran	71336-1000	1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE	2030-11-10
Alnylam Pharmaceuticals Inc	ONPATTRO	patisiran	71336-1000	CHOLESTEROL	2030-11-10
Alnylam Pharmaceuticals Inc	ONPATTRO	patisiran	71336-1000	MC-3	2030-11-10
Alnylam Pharmaceuticals Inc	ONPATTRO	patisiran	71336-1000	MONOBASIC POTASSIUM PHOSPHATE	2030-11-10
Alnylam Pharmaceuticals Inc	ONPATTRO	patisiran	71336-1000	SODIUM CHLORIDE	2030-11-10
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for patisiran

Excipient focus: 1,2-DIMYRISTOYL-SN-GLYCERO-3-CARBOXAMINOPROPYLPOLYETHYLENE GLYCOL 2000 METHYL ETHER

patisiran drug variants containing 1,2-DIMYRISTOYL-SN-GLYCERO-3-CARBOXAMINOPROPYLPOLYETHYLENE GLYCOL 2000 METHYL ETHER

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Alnylam Pharmaceuticals Inc	patisiran	71336-1000
>Company	>Ingredient	>NDC

patisiran drug variants not containing 1,2-DIMYRISTOYL-SN-GLYCERO-3-CARBOXAMINOPROPYLPOLYETHYLENE GLYCOL 2000 METHYL ETHER

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE

patisiran drug variants containing 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Alnylam Pharmaceuticals Inc	patisiran	71336-1000
>Company	>Ingredient	>NDC

patisiran drug variants not containing 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CHOLESTEROL

patisiran drug variants containing CHOLESTEROL

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Alnylam Pharmaceuticals Inc	patisiran	71336-1000
>Company	>Ingredient	>NDC

patisiran drug variants not containing CHOLESTEROL

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MC-3

patisiran drug variants containing MC-3

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Alnylam Pharmaceuticals Inc	patisiran	71336-1000
>Company	>Ingredient	>NDC

patisiran drug variants not containing MC-3

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MONOBASIC POTASSIUM PHOSPHATE

patisiran drug variants containing MONOBASIC POTASSIUM PHOSPHATE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Alnylam Pharmaceuticals Inc	patisiran	71336-1000
>Company	>Ingredient	>NDC

patisiran drug variants not containing MONOBASIC POTASSIUM PHOSPHATE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM CHLORIDE

patisiran drug variants containing SODIUM CHLORIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Alnylam Pharmaceuticals Inc	patisiran	71336-1000
>Company	>Ingredient	>NDC

patisiran drug variants not containing SODIUM CHLORIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE

patisiran drug variants containing SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Alnylam Pharmaceuticals Inc	patisiran	71336-1000
>Company	>Ingredient	>NDC

patisiran drug variants not containing SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: WATER

patisiran drug variants containing WATER

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Alnylam Pharmaceuticals Inc	patisiran	71336-1000
>Company	>Ingredient	>NDC

patisiran drug variants not containing WATER

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.